STOCK TITAN

Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Longeveron Inc. (NASDAQ: LGVN) will report its first quarter 2024 financial results and provide a business update on May 14, 2024. The company, a clinical stage biotechnology firm focusing on regenerative medicines, will host a conference call and webcast at 5:00 p.m. ET the same day.

Positive
  • None.
Negative
  • None.

MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will report first quarter 2024 financial results and provide a business update on Tuesday, May 14, 2024 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 5:00 p.m. ET.

Conference Call Details:
    
Conference Call Number:  1.877.407.0789
    
Conference ID:  13745868
    
Call meTM Feature:  Click Here
    
Webcast:  Click Here


An archived replay of the webcast will be available on the “Events & Presentations” section of the Company’s website following the conference.

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B™, an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty. For more information, visit www.longeveron.com or follow Longeveron on LinkedIn, X, and Instagram.

Investor Contact:

Derek Cole
Investor Relations Advisory Solutions 
derek.cole@iradvisory.com


FAQ

When will Longeveron report its first quarter 2024 financial results?

Longeveron will report its first quarter 2024 financial results on May 14, 2024.

What is the stock symbol for Longeveron?

The stock symbol for Longeveron is LGVN.

What time will the conference call and webcast take place on May 14, 2024?

The conference call and webcast will take place at 5:00 p.m. ET on May 14, 2024.

Where can I find the archived replay of the webcast?

The archived replay of the webcast will be available on the 'Events & Presentations' section of Longeveron's website after the conference.

Longeveron Inc.

NASDAQ:LGVN

LGVN Rankings

LGVN Latest News

LGVN Stock Data

15.55M
1.13M
6.71%
14.27%
1.12%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
MIAMI